The Canadian MS Society is not happy...
...because those who have the determination and the means are going overseas for the "liberation" treatment that unblocks a blood vessel and results in improvement. Tremendous improvement.
Neil, someone who is an old friend of the family, has been in a wheelchair for some time. His letters to the newspaper in the city of Saskatoon are well done! Long story short, he left for Germany on the 23rd (with a companion), had the procedure on the 26th, and came home on the 28th.
"So," I said today (31st), "what's NEW?"
He said, "I got my feet back." They have been completely numb from the ankle down; he can now wiggle his toes and feel a piece of paper on the floor under his foot.
His one hand, which was bent weirdly, is relaxing and resuming normal shape. His eyesight is clearer and brighter. AND - instead of lying in bed in one position, he can now turn over in bed.
He sees his GP tomorrow and his GP is going to refer him for physio. As he says, he needs to learn to walk again, and has a lot of work ahead.
My sister died from MS - it was 4 years ago in April. Yes, I choke on the "if only" - but thank GOD others have a real chance at having a good life. :love:
Needless to say, some provincial governments are calling for this therapy to be tested in Canada...but some established conservative people in the health field (ie MS society et al) might well be out of a job.
I am just WOW on this.:D
Health minister rejects MS therapy trial
Link to this article is at the bottom. Please also browse through the reader comments below it.
*********************************************
Health minister rejects MS therapy trial
Canada won't fund clinical trial of so-called liberation therapy for multiple sclerosis as yet
Last Updated: Wednesday, September 1, 2010 | 1:10 PM
CBC News
Some Canadians with multiple sclerosis are going overseas for a controversial procedure known as liberation therapy that aims to improve blood flow from the brain. It is too early for a pan-Canadian clinical trial to test the treatment, Health Minister Leona Aglukkaq says.Some Canadians with multiple sclerosis are going overseas for a controversial procedure known as liberation therapy that aims to improve blood flow from the brain. It is too early for a pan-Canadian clinical trial to test the treatment, Health Minister Leona Aglukkaq says. (CBC)
The Canadian government will not fund a clinical trial of the so-called liberation therapy for multiple sclerosis at this time, Health Minister Leona Aglukkaq says.
Aglukkaq spoke to reporters in Ottawa on Wednesday, a day after a panel of North American experts announced they unanimously recommended against supporting a clinical trial of the treatment in Canada as yet.
Aglukkaq commissioned the expert panel's report from the Canadian Institutes of Health Research, which funds medical research, and the MS Society of Canada.
"I feel the most prudent course of action at this time is to accept the recommendation of the country's leading researchers," Aglukkaq told a news conference.
P.O.V.:
Should the federal government fund "liberation therapy" trials? Take our poll.
Liberation therapy is based on an unproven theory of chronic cerebrospinal venous insufficiency (CCSVI) — put forward by Italian doctor Paolo Zamboni — that blocked veins in the neck or spine are to blame for MS. Zamboni proposed treating multiple sclerosis by inflating small balloons to open up veins.
Some Canadians are spending thousands of dollars to seek the experimental treatment overseas.
CIHR head Dr. Alain Beaudet said experts weren't convinced Zamboni's procedure works and is safe. Beaudet said he advised Aglukkaq that it was too early to back clinical trials.
Safety questions
In June, the MS society and its U.S. counterpart awarded a combined $2.4 million in research grants to diagnostic studies aimed at testing whether Zamboni's theory is correct, by checking for abnormal blood flow in the veins in people with MS and healthy controls using ultrasound, MRI or catheters with dye. The research projects are expected to take two years.
Yves Savoie, the president of the MS Society of Canada, said Wednesday that his organization would monitor the results of the studies.
If they suggest there is a clear link between occluded veins and MS, then the society will recommend that a clinical trial testing vein opening be started quickly.
Beaudet said Zamboni's treatment is currently too risky to try in Canada.
"Any procedure where you inject a catheter in a vein, where you compress the vein, where you risk damage to the internal sheath of the vein, is not without risk."
But MS patient Tim Cant of Whitehorse, who travelled to India to undergo liberation therapy earlier this year, said he and others have seen their conditions improve.
"They talk about us being … one of the best medical systems in the world," Cant told CBC News on Wednesday. "Why is it so many Canadians are now travelling to other places in the world to get this operation done?"
Cant, who was diagnosed with MS three years ago, said if politicians could experience first-hand the physical and mental pain that multiple sclerosis inflicts on people, they would fund clinical trials without hesitation.
Objective measurements
To show liberation therapy works would require objective measurements, such as changes in muscle strength, a reduction in the frequency of relapses of MS symptoms or differences in MRI brain scans, Beaudet said.
Aglukkaq agreed that if evidence from the research projects supports the launching of a clinical trial, then the federal government would allow a pan-Canadian study of the ballooning therapy, called angioplasty, on patients.
For months, the federal Liberal position has been that the government should fund research to figure out whether the treatment is of benefit to Canadian patients or not, Liberal Leader Michael Ignatieff said Wednesday at the party's caucus meeting in Baddeck, N.S.
Ignatieff said it's not appropriate for politicians to say which treatment is going to work, but for doctors and scientists to do so, assisted by the federal government.
Saskatchewan Premier Brad Wall has said his province would fund a clinical trial into the procedure if it receives a research proposal for one.
Read more: http://www.cbc.ca/canada/calgary/sto...#ixzz0yJ9dtxTy
Alta. woman returns home after undergoing controversial procedure for MS
http://calgary.ctv.ca/servlet/an/loc...ub=CalgaryHome
Alta. woman returns home after undergoing controversial procedure for MS
Christine Engelhardt spent thousands of dollars on controversial MS treatment in Costa Rica.
Updated: Wed Sep. 01 2010 16:56:35
ctvedmonton.ca
http://www.ctv.ca/servlet/ImageShrin...16.jpg,430,241
A Stony Plain nurse is back home after receiving a controversial new treatment for multiple sclerosis in Costa Rica.
Christine Engelhardt has been living with MS for 10 years. She says one of her first symptoms was blindness in her left eye.
Engelhardt is now one of many MS sufferers who've chosen to travel out of the country to receive the liberation treatment, which involves the widening of the veins.
The procedure is based on research from an Italian doctor who found blocked veins in some MS patients could be reversed by a procedure similar to balloon angioplasty. Several countries are offering the treatment and have reported successful results but it is still not available in Canada.
Engelhardt spent $20,000 to obtain the treatment in Costa Rica. She says two weeks ago she couldn't pour coffee without spilling because her hands had no strength. Her symptoms also included headaches, loss of balance, and severe muscle spasms.
"My fatigue was insane. I couldn't make it through a whole day," she said.
She says after undergoing the treatment in Central America, she felt instant change.
"When I first woke up from the anesthesia I could feel my left foot, which I haven't been able to feel for about two years."
Engelhardt says she is disappointed the treatment hasn't been approved in Canada.
"I just wish everyone had this opportunity to feel better because we deserve it...we deserve the choice."
On Wednesday, officials announced the federal government would not fund clinical trials in Canada.
"There's no evidence that venous insufficiency is linked in any way to multiple sclerosis," said Dr. Alain Beaudet with the Canadian Institute of Health Research.
Health Minister Leona Aglukkaq said the federal government will assemble a working group to study data from seven studies of the treatment, which are now underway.
"To ensure that we have the evidence to support this procedure, we need to do the research," Aglukkaq said. "And once we have that, we will proceed -- if there is enough evidence from the seven research projects already underway around this subject -- we will proceed with pan-Canadian clinical trials. We will support that. At this point in time, we do not have the evidence to proceed."
Aglukkaq said the studies are expected to take two years to complete.
With files from Susan Amerongen and CTV.ca News Staff
**********************************************
Countries that are offering the procedure: Scotland, Germany, India, Poland, Costa Rica...that's all I know of. The first two, at least, aren't "third-world" countries.
Defiant Saskatchewan refuses to bend on clinical trials for MS treatment
http://www.theglobeandmail.com/news/...rticle1693372/
Caroline Alphonso and Gloria Galloway
Toronto and Ottawa — From Thursday's Globe and Mail Published on Wednesday, Sep. 01, 2010 10:30PM EDT Last updated on Thursday, Sep. 02, 2010 6:38AM EDT
Saskatchewan is not backing down from its plan to start clinical trials on a controversial new treatment for multiple sclerosis, even though the federal Health Minister, the Multiple Sclerosis Society of Canada and the health-research community insist it’s too risky and that the province lacks the capacity to forge ahead.
The province’s Health Minister, Don McMorris, said once Saskatchewan gets the green light from researchers conducting diagnostic tests on patients, it will move toward accepting clinical trial proposals for the so-called liberation therapy, which could be as early as the new year.
“We started down this road without needing the approval or disapproval of the federal government. Provinces do research in areas on a regular basis. We feel this is an area that we need to take the leadership role, and we’re not backing down from that position,” Mr. McMorris said in an interview on Wednesday.
Federal Health Minister Leona Aglukkaq has accepted the position of the Canadian Institutes of Health Research that it’s too soon to conduct clinical trials on the procedure pioneered by Italian doctor Paolo Zamboni. The MS Society added leverage to Ottawa’s position on Wednesday by saying Saskatchewan can’t conduct a meaningful clinical trial on its own.
Yves Savoie, president of the MS Society of Canada, said a true clinical trial must be conducted at more than one institution and in more than one province. Because MS is so variable, “it will require well over 1,000 participants that will be recruited through a number of centres,” he said. “A single province or a single site would simply not be a way to get to the definitive answers that we all want.”
Saskatchewan has the highest rate of MS in the country.
Officials in the province rejected the notion that their clinical trials, if approved by the necessary regulatory bodies, would be lacking in science or thorough research. A spokeswoman for Premier Brad Wall said the province is not opposed to a joint study with another province. Researchers in Saskatchewan are already about to start conducting diagnostic testing of Dr. Zamboni’s theory with their counterparts in British Columbia, one of the seven projects funded by MS Societies in Canada and the United States.
“We don’t accept the fact that a thousand individuals would be required for a clinical trial. There is a clinical trial right now in New York with a much smaller group – and have been for many other clinical trials for various medical research. We would take our lead from the specialists putting together proposals,” said Kathy Young, communications director for Mr. Wall.
Liberation therapy has not only pitted the federal government against one province, but it also has been hotly debated in the MS community since Dr. Zamboni published a study suggesting the disease is a vascular disorder caused by vein blockages that lead to a buildup of iron rather than an autoimmune disease. He said it could be treated with a simple surgical procedure – angioplasty.
Studies on his theory have had mixed results. Researchers in Germany and Sweden recently found no unusual blockages in the veins of multiple sclerosis patients compared with those of control groups.
What also remains unclear – and what the diagnostic studies in Canada and around the world may determine – is whether multiple sclerosis causes blocked veins or if blockage of the veins leading from the brain causes MS, as hypothesized by Dr. Zamboni. The CIHR recommended on Tuesday that therapeutic clinical trials be put on hold until the results come in from the seven research projects to determine if there is a link between vein blockages and the disease.
But the uncertainty hasn’t stopped multiple sclerosis patients from receiving treatment. While the procedure has yet to undergo clinical trials in Canada, many here have shelled out thousands of dollars for the unproven and experimental treatment in countries such as India and Poland.
Saskatchewan’s announcement in July that it would finance clinical trials put it at the forefront of Canadian efforts to introduce a treatment. Newfoundland and Labrador has told the CBC it is also willing to help fund clinical trials.
“When we look at the prevalency of MS within our population, when you look at the number of people that have gone overseas to have the procedure done and the anecdotal evidence that is coming back, it puts a strong case,” Mr. McMorris said. “What we want to do as a government is take a leadership role and either prove or dispel this so-called treatment.”
ETA: Comments section on this article: http://www.theglobeandmail.com/news/...rticle1693372/